Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07309887) titled 'This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer' on Dec. 16, 2025.

Study Type: Observational

Primary Sponsor: Samsung Medical Center

Condition: Early Breast Cancer

Recruitment Status: Not recruiting

Date of First Enrollment: December 17, 2025

Target Sample Size: 100000

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07309887

Disclaimer: Curated by HT Syndication....